Gossamer Bio, Inc. (GOSS)
0.3979
+0.02
(+4.30%)
USD |
NASDAQ |
Mar 26, 11:12
Gossamer Bio Cash from Investing (Quarterly) : 73.16M for Dec. 31, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Vanda Pharmaceuticals, Inc. | 44.87M |
| Madrigal Pharmaceuticals, Inc. | 27.58M |
| Kyntra Bio, Inc. | -51.71M |
| Artelo Biosciences, Inc. | 0.1976M |
| Axsome Therapeutics, Inc. | -0.071M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -48.31M |
| Cash from Financing (Quarterly) | 3.955M |
| Free Cash Flow | -171.34M |
| Free Cash Flow Per Share (Quarterly) | -0.2132 |
| Free Cash Flow to Equity (Quarterly) | -48.34M |
| Free Cash Flow to Firm (Quarterly) | -45.57M |
| Free Cash Flow Yield | -189.6% |